A Quantitative Gene Expression Profile of Matrix Metalloproteinases (MMPS) and Their Inhibitors (TIMPS) in the Myocardium of Patients With Deteriorating Heart Failure Requiring Left Ventricular Assist Device Support

Journal of Heart and Lung Transplantation

Volumn 25, Issue 12, 2006, Pages 1413-1419

  Felkin, Leanne E ^a   Birks, Emma J ^a,b   George, Robert ^a,b   Wong, Sissie ^c   Khaghani, Asghar ^b   Yacoub, Magdi H ^a   Barton, Paul J R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHOOL CHILD;

ADOLESCENT; ADULT; CARDIAC OUTPUT, LOW; CHILD; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASES; MIDDLE AGED; MYOCARDIUM; SEVERITY OF ILLNESS INDEX; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 33845485056     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.09.006     Document Type: Article

References (28)

1. Birks E.J., Yacoub M.H., Banner N.R., and Khaghani A. The role of bridge to transplantation: should LVAD patients be transplanted?. Curr Opin Cardiol 19 (2004) 148-153
2. Frazier O.H., Benedict C.R., Radovancevic B., et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 62 (1996) 675-681
3. Hetzer R., Muller J., Weng Y., Wallukat G., Spiegelsberger S., and Loebe M. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg 68 (1999) 742-749
4. Birks E.J., Tansley P., Hardy J., George R.S., Bowles C.T., Burke M., Banner N.R., Khaghani A., and Yacoub M.H. Left ventricular assist device and drug therapy for the reversal of heart failure. New Eng J Med 355 (2006) 23-34 18
5. Burkhoff D., Klotz S., and Mancini D.M. LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery. J Card Fail 12 (2006) 227-239
6. Barton P.J.R., Birks E.J., Felkin L.E., Cullen M.E., Koban M.U., and Yacoub M.H. Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure. J Heart Lung Transplant 22 (2003) 738-744
7. Birks E.J., Latif N., Owen V.J., et al. Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices. Circulation 104 Suppl. I (2001) I-233-I-240
8. Birks E.J., Felkin L.E., Banner N.R., Khaghani A., Barton P.J.R., and Yacoub M.H. Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices. J Heart Lung Transplant 23 (2004) 228-235
9. Li Y.Y., McTiernan C.F., and Feldman A.M. Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. Cardiovasc Res 42 (1999) 162-172
10. Siwik D.A., Chang D.L.-F., and Colucci W.S. Interleukin-1β and tumor necrosis factor-α decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86 (2000) 1259-1265
11. Xie Z., Singh M., and Singh K. Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. J Biol Chem 17 (2004) 39513-39519 279
12. Spinale F.G., Coker M.L., Heung L.J., et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 102 (2000) 1944-1949
13. Li Y.Y., Feldman A.M., Sun Y., and McTiernan C. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 98 (1998) 1728-1734
14. Felkin L.E., Taegtmeyer A.B., and Barton P.J.R. Real-time quantitative pcr in cardiac transplant research. In: Hornick P., and Rose M.L. (Eds). Transplantation immunology: methods and protocols (2006), Humana Press, Totowa, NJ 305-329
15. Relative quantitation of gene expression: ABI PRISM 7700 Sequence detection system. Applied Biosystems User Bulletin #2: Rev B (2001), Applied Biosysems, Foster City, CA
16. Welgus H.G., Jeffrey J.J., and Eisen A.Z. The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem 256 (1981) 9511-9515
17. Tyagi S.C., Kumar S., Voelker D.J., Reddy H.K., Janicki J.S., and Curtis J.J. Differential gene expression of extracellular matrix components in dilated cardiomyopathy. J Cell Biochem 63 (1996) 185-198
18. Klotz S., Foronjy R.F., Dickstein M.L., et al. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation 112 (2005) 364-374
19. Kim H.E., Dalal S.S., Young E., Legato M.J., Weisfeldt M.L., and D'Armiento J.D. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J Clin Invest 106 (2000) 857-866
20. Gunja-Smith Z., Morales A.R., Romanelli R., and Woessner Jr. J.F. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links. Am J Pathol 148 (1996) 1639-1648
21. Lindsey M.L., Goshorn D.K., Squires C.E., et al. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc Res 66 (2005) 410-419
22. Frangogiannis N.G., Smith C.W., and Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 53 (2002) 31-47
23. Peterson J.T., Li H., Dillon L., and Bryant J.W. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 46 (2000) 307-315
24. Pauschinger M., Rutschow S., Chandrasekharan K., et al. Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. Eur J Heart Fail 7 (2005) 444-452
25. Herman M.P., Sukhova G.K., Libby P., et al. Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling. Circulation 104 (2001) 1899-1904
26. Lambert E., Dasse E., Haye B., and Petitfrere E. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49 (2004) 187-198
27. Polyakova V., Hein S., Kostin S., Ziegelhoeffer T., and Schaper J. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 44 (2004) 1609-1618
28. Tummalapalli C.M., Heath B.J., and Tyagi S.C. Tissue inhibitor of metalloproteinase-4 instigates apoptosis in transformed cardiac fibroblasts. J Cell Biochem 80 (2001) 512-521